Latest News

Date Title Topic
30 Jun 2016 World GI 2016 Press Release: Chemoradiotherapy After Surgery for Gastric Cancer Shows Similar Outcomes to Post-Operative Chemotherapy Gastrointestinal cancers - Anticancer agents & Biologic therapy
29 Jun 2016 World GI 2016 Press Release: Anti-PD-L1 Immunotherapy Shows Response in Microsatellite-Stable Metastatic Colorectal Cancer in Combination with MEK Inhibition Gastrointestinal cancers - Cancer Immunology and Immunotherapy
27 Jun 2016 Press Release: EMA ESMO Workshop - Optimising the use of single arm trials in cancer drug development Anticancer agents & Biologic therapy
23 Jun 2016 ESMO Preceptorship on Breast Cancer – Portugal
23 Jun 2016 Epithelial-Mesenchymal Transition as a New Target Translational research - Anticancer agents & Biologic therapy
Finance Coordinator
20 Jun 2016 NICE UK Updates its Quality Standard in Breast Cancer Breast cancer
14 Jun 2016 NICE UK Issues New Guidance for Cabazitaxel Genitourinary cancers - Anticancer agents & Biologic therapy
13 Jun 2016 ESMO 2016 Media Alert: From Disease Treatment to Patient Care
07 Jun 2016 EMA Recommends Extension of Therapeutic Indications for Brentuximab Vedotin Haematologic malignancies - Anticancer agents & Biologic therapy
07 Jun 2016 ESMO Workshop: Cancer Patient Advocacy Networks Driving Research
03 Jun 2016 ESMO is Hiring!
02 Jun 2016 Everolimus for the Treatment of Advanced, Non-Functional Neuroendocrine Tumours of the Lung or Gastrointestinal Tract (RADIANT-4): a Randomised, Placebo-Controlled, Phase 3 Study Endocrine cancers
31 May 2016 EMA Recommends to Refuse Marketing Authorisation for Ixazomib Haematologic malignancies - Anticancer agents & Biologic therapy
30 May 2016 Withdrawal of the EU Marketing Authorisation Application for Rociletinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy